Trimethobenzamide
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171805This classification denotes an antiemetic agent with the molecular formula C21H28N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W2X096QY97, chemically known as 4-(2-dimethylaminoethoxy)-n-(3,4,5-trimethoxybenzoyl)benzylamine but generally known as trimethobenzamide, which bears US NIH Compound Identifier 5577. European Medicines Agency schedules Trimethobenzamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11309MIG. The term TRIMETHOBENZAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). TRIMETHOBENZAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimethobenzamide under HS 29242995 and SITC 51479. As of Q4 2014, TRIMETHOBENZAMIDE remains the US FDA Preferred Term for this commodity. Trimethobenzamide bears US NLM identifiers UMLS ID C0077163 and NCI Concept Code C61989. SMILES: O(CCN(C)C)C1CCC(CNC(=O)C2CC(OC)C(OC)C(OC)C2)CC1.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.